Blog
U.S. Listing | Chengdaotong Environmental Protection, Yingscience Technology, and 6 other U.S. IPOs received supplementary document requirements for overseas issuance and listing filing



Gold Box Group | Listing Guidance | US Listing |IPO|SPAC|RTO|US Listing | Professional US Listing Guidance Institution | US Stock Listing |
Today’s Quick Overview of US Listing News!
On September 1, the International Department of the China Securities Regulatory Commission (CSRC) issued supplementary material requests to 7 companies, 6 of which are US IPOs and 1 is a Hong Kong IPO. Details below:
ZEEKR Intelligent (confidential submission, filing notice issued) (NASDAQ)
Please supplement the following matters and have your lawyer verify and issue a clear legal opinion:
I. Regarding the equity structure, please supplement:
(1) The compliance of the equity structure establishment, including but not limited to foreign exchange administration, overseas investment and other regulatory procedures involved in the establishment of overseas equity structure and reverse mergers, and the payment of taxes and fees in accordance with the law;
(2) The specific transaction arrangements between relevant parties, including but not limited to the time, amount, channel and method of capital support for domestic entities, and relevant capital flows and profit transfer arrangements.
II. Regarding changes in equity, please supplement:
(1) The similarities and differences between Pre-A and Series A preferred shares, whether there are special rights arrangements and their impact on the company’s operations and control, and whether such impacts are still ongoing;
(2) The payment status of consideration and tax payment for all share changes since the issuer’s establishment, as well as the domestic regulatory procedures such as foreign exchange administration and overseas investment that have been fulfilled; the latest progress of overseas investment procedures for shareholders of the shares to be issued;
(3) The compliance of the employee stock ownership plan, including but not limited to the fulfillment of domestic regulatory procedures such as foreign exchange administration for the employee stock ownership plan; whether there are unconfirmed grantees in the employee stock ownership plan; the reasons and background for non-issuer system employees to participate in the employee stock ownership plan, the source of funds, and whether there is any improper transfer of benefits.
III. Regarding personal information protection and data security, please supplement:
The situation of your company’s developed and operated products such as apps and mini-programs, explain whether it involves providing information content to third parties; if so, explain the type of information content, and the measures for protecting the security of information content; the scale of user information collected and stored by your company, the situation of data collection and use, and the arrangements or measures for personal information protection and data security before and after listing.
WeRide (confidential submission, filing notice issued) (NASDAQ)
Please supplement the following matters and have your lawyer verify and issue a clear legal opinion:
I. Regarding changes in equity:
(1) Please verify the compliance of the equity incentive plan, including but not limited to the fulfillment of domestic regulatory procedures such as foreign exchange administration for the equity incentive plan, and explain whether there are external personnel or unconfirmed grantees in the equity incentive plan;
(2) Please list the amount, consideration payment status and tax payment for all share changes since the issuer’s establishment, as well as the domestic regulatory procedures such as foreign exchange administration and overseas investment that have been fulfilled;
(3) The similarities and differences between different types of preferred shares, whether there are differences in the price of capital increase, whether there are special rights arrangements and their impact on the company’s operations and control, and whether such impacts are still ongoing.
II. Regarding foreign investment access: the reasons why the adjusted contractual control structure does not involve businesses prohibited or restricted by the "Special Administrative Measures for Foreign Investment Access (Negative List)" (2021 edition), the progress of canceling relevant qualifications and whether it will have a material impact on the company’s business operations.
III. Regarding the equity structure:
(1) The compliance of the equity control structure, including but not limited to regulatory procedures such as foreign exchange administration and overseas investment involved in the establishment and reverse mergers, and the payment of taxes and fees in accordance with the law;
(2) The specific transaction arrangements between relevant parties under the equity control structure, including but not limited to the time, amount, channel and method of capital support for domestic entities, and relevant capital flows and profit transfer arrangements.
HealthTech Holdings (confidential submission converted to public) (NASDAQ)
Please supplement the following matters and have your lawyer verify and issue a clear legal opinion:
I. Regarding your company’s equity structure, please explain:
(1) The consideration and pricing basis for 6 natural person shareholders including Fan Zhen transferring the equity of Beijing HealthTech, the domestic operating entity, to WOFE company HealthTech in October 2022, as well as the payment status of consideration and taxes and fees (if any);
(2) The source of funds for shareholder Wu Hongli to subscribe for the issuer’s equity, and the fulfillment of regulatory procedures such as foreign exchange administration;
(3) The reasons and rationality for introducing shareholders Wu Hongli, Zhao Tao, Sun Wenpu and Li Han through capital increase in Beijing HealthTech;
(4) The reasons and compliance for the unpaid registered capital of Beijing HealthTech, and its impact on the company’s operations and solvency.
II. Regarding operational compliance, please explain:
(1) Whether your company’s business operations comply with regulations such as the "Measures for the Administration of Medical Advertisements" and the "Notice on In-depth Development of Internet Advertisement Rectification Work";
(2) The situation and scale of personal information collected, used, analyzed and stored, the arrangements or measures adopted for personal information protection and data security, and whether they comply with national laws and regulations such as the Personal Information Protection Law;
(3) The basis for determining the rebate ratio, whether the internal governance and monitoring measures related to the rebate model are sound, and whether there are off-book rebates or other violations of relevant laws and regulations such as the "Anti-Unfair Competition Law of the People’s Republic of China".
III. Please supplement the specific situation of your company’s current issuance and listing plan in accordance with the requirements of the "Regulatory Guidelines for Application – Overseas Issuance and Listing No. 2: Guidelines for the Content and Format of Filing Materials", including but not limited to the number of shares to be issued, the estimated amount of funds raised, etc.
Hardening Technology (NASDAQ)
Please supplement the following matters and have your lawyer verify and issue a clear legal opinion:
I. Regarding the equity structure, please explain:
(1) The correspondence between the ultimate shareholders of major shareholders Hinomoto Limited and Redarmor Inc. and the ultimate shareholders of Zhongshan Siter, the major domestic operating entity, original shareholders Zhongshan Hongku Investment Management Partnership (Limited Partnership) and Zhongshan Hesu Management Consulting Partnership (Limited Partnership);
(2) The pricing basis and fairness of Chen Nianchun’s capital increase in Zhongshan Siter in May 2021, and the acquisition of Zhongshan Siter’s equity by the issuer’s domestic subsidiary Zhongshan Hewell, the timely declaration and payment of taxes and fees related to the above equity transfers, and whether the reporting obligations stipulated in the "Measures for Foreign Investment Information Reporting" have been fulfilled.
II. Regarding changes in equity, please provide a conclusive opinion on the legality and compliance of share changes since the establishment of Zhongshan Siter, the major domestic operating entity.
III. Regarding special verification, please have your lawyer issue a clear overall conclusive opinion on whether there are circumstances that prohibit overseas issuance and listing as stipulated in Article 8 of the "Trial Measures for Administration" for this issuance.
Citydo Environmental Protection (NASDAQ)
Please supplement the following matters and have your lawyer verify and issue a clear legal opinion:
I. Regarding the equity structure, please explain:
(1) The pricing basis and fairness of Hong Kong Citydo and Hong Kong Chaoxiong Investment acquiring all equity of Shenzhen Citydo through mergers and acquisitions in 2015, the timely declaration and payment of taxes and fees related to the above equity transfers, and whether the reporting obligations stipulated in the "Measures for Foreign Investment Information Reporting" have been fulfilled;
(2) The specific reason why Li Yunwu acquired shares held by special purpose companies from Luo Zhijian and Li Hong respectively in 2015, and the 37th Article change registration has not been handled so far;
(3) The equity structure diagram of the subsidiary is inconsistent with the equity structure diagram attached to the legal opinion, please provide the final version of the equity structure diagram;
(4) The reasons and compliance for the unpaid registered capital of Shenzhen Citydo, the major domestic operating entity, and whether it has a material impact on the company’s business operations and solvency;
(5) The basis for determining the transfer price and fairness of selling the equity of the Xiamen subsidiary for $5,000 in 2022.
II. Regarding shareholder information, please list the establishment time, type and operation mode, term, rights and obligations of the parties, and beneficiaries of the upper trust Harneys Trustees Limited of shareholder Luo Jia Holdings Limited.
Contineo (NASDAQ)
Please supplement the following matters and have your lawyer verify and issue a clear legal opinion:
The tax declaration and payment status of your company’s asset acquisition and restructuring with CATALYST BIOSCIENCES, INC. in accordance with the relevant provisions of the "Announcement on Several Issues Concerning the Enterprise Income Tax on Indirect Transfer of Property by Non-Resident Enterprises".
On the same day, the CSRC also updated the filing status of domestic enterprises’ overseas issuance of securities and listing (initial public offering and full circulation) (as of August 31, 2023), with a total of 105 domestic enterprises filed (excluding those that have completed).
9 new enterprises were added last week, 8 going to Hong Kong and 1 going to the US. The 9 enterprises are: Chenxi Travel, Baicha Baidao,黑芝麻智能, Zhongshan Jianye, Fendou Technology (US listing), Marton Medical, Sanhua Intelligent, Weier Pharma, and SF Holding.
The list of newly added enterprises last week is as follows:

Chinese concept stocks' US listings warm up,the approval process for overseas issuance and listing filings of enterprises has accelerated, in2023theUS stock market has seen strong growth,Chinese enterprises' confidence in listing in the US is also growing. Jinhe Group's Xiaojin will share daily hot information on US listings to help enterprises soar in their listings!

Disclaimer: Part of the information in this article comes from the internet. The content of this article is for sharing purposes only. If there are any content or copyright issues, please contact us and we will handle them as soon as possible.
Originally published on 金盒企业管理集团




